Cognitive Clinical Trials

Gilbert, Arizona 85297

0 studies enrolling now · 7 studies all time

What they study most

Alzheimer Disease, Alzheimer's Disease, Neuropsychiatric Symptoms Related to Neurodegenerative Disease, Severe Alzheimer Disease

Studies at this site

• Open-Label Extension of the PTI-125-04 Study in Mild-to-Moderate Alzheimer's Disease — Stopped early
• Simufilam (PTI-125), 100 mg, for Mild-to-moderate Alzheimer's Disease Patients — Completed
• A Safety Study of Pimavanserin in Adult and Elderly Subjects Experiencing Neuropsychiatric Symptoms Related to Neurodegenerative Disease — Completed
• Extension Study of Pimavanserin in Adult Subjects With Neuropsychiatric Symptoms Related to Neurodegenerative Disease — Completed
• Safety and Efficacy Study of ALZT-OP1 in Subjects With Evidence of Early Alzheimer's Disease — Completed
• PTI-125 for Mild-to-moderate Alzheimer's Disease Patients — Completed
• A Study to Assess the Safety of GRF6019 Infusions in Subjects With Severe Alzheimer's Disease — Completed